Kai Lin Liu
Chief Investment Officer bei Beijing Biostar Pharmaceuticals Co. Ltd.
Aktive Positionen von Kai Lin Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Chief Investment Officer | 01.07.2020 | - |
| Unternehmenssekretär | 01.09.2020 | - | |
| Investor Relations Kontakt | - | - |
Karriereverlauf von Kai Lin Liu
Ausbildung von Kai Lin Liu
| Nankai University | Graduate Degree |
Statistik
International
| China | 3 |
Operativ
| Graduate Degree | 1 |
| Chief Investment Officer | 1 |
| Investor Relations Contact | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Börse
- Insiders
- Kai Lin Liu
- Erfahrung